HK2 and non-small cell lung carcinoma: For instance, Shi et al. (2021) demonstrated that EV circ_0008928, derived from CDDP-resistant NSCLC serum, could reduce CDDP sensitivity and promote cell proliferation, migration, invasion, and glycolysis metabolism by modulating the miR-488/HK2 axis.